CNBC
Regeneron Pharmaceuticals said earlier this month that it will acquire “substantially all” of 23andMe’s assets for $256 million…
Read More
23andMe to delist from Nasdaq, deregister with SEC
Anthony Kucera
00:21
Regeneron Pharmaceuticals said earlier this month that it will acquire “substantially all” of 23andMe’s assets for $256 million…
